Synchronous primary ovarian and endometrial cancers: A population-based assessment of survival

Obstetrics and Gynecology

Volumn 113, Issue 4, 2009, Pages 783-789

  Bandera, Elisa V ^a   Williams, Melony G ^b   Demissie, Kitaw ^b   Rodríguez Rodríguez, Lorna ^b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; DEMOGRAPHY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CANCER; PAPILLOMA; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; ADOLESCENT; AGE; COMORBIDITY; ENDOMETRIUM TUMOR; HEALTH SURVEY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; OVARY TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COMBINED MODALITY THERAPY; COMORBIDITY; DEMOGRAPHY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65649096911     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31819c7bdf     Document Type: Article

References (17)

1. Chiang YC, Chen CA, Huang CY, Hsieh CY, Cheng WF. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer 2008;18:159-64.
2. Coli A, Dell'Isola C, Bigotti G. Synchronous tumors: a proposal for standardization. Tumori 2002;88:433-4.
3. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985;16:28-34.
4. Scully R, Young R, Clement P. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of Tumor Pathology. Washington (DC): Armed Forces Institute of Pathology; 1998. Tables 5-1-5-3.
5. Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 2001;83: 355-62.
6. Sheu BC, Lin HH, Chen CK, Chao KH, Shun CT, Huang SC. Synchronous primary carcinomas of the endometrium and ovary. Int J Gynaecol Obstet 1995;51:141-6.
7. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004;94:456-62.
8. Kondi-Pafiti A, Grapsa D, Liapis A, Papadias K, Kairi-Vassilatou E, Hasiakos D. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis? Eur J Gynaecol Oncol 2008;29:256-9.
9. Howe HL, Weinstein R, Hotes J, Kohler B, Roffers SD, Goodman MT. Multiple primary cancers of the ovary in the United States, 1992-1997. Cancer 2003;97:2660-75.
10. Surveillance, Epidemiology, and End Results (SEER) Program. Limited-Use Data (1973-2005). DCCPS, Surveillance Research Program, Cancer Statistics Branch. Bethesda (MD): National Cancer Institute; 2008.
11. Johnson CH. SEER program coding and staging manual 2004, revision 1. Bethesda (MD): National Cancer Institute, NIH Pub. No. 04-5581;2004.
12. Kosary CL. Cancer of the corpus uteri. In: Ries LAG YJ, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults. US SEER Program, 1988-2001, patient and tumor characteristics. Bethesda (MD): National Cancer Institute, NIH Pub. No. 07-6215;2007. p. 123-32.
13. Kosary CL. Cancer of the ovary. In: Ries LAG YJ, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults. US SEER Program, 1988-2001, patient and tumor characteristics. Bethesda (MD): National Cancer Institute, NIH Pub. No. 07-6215; 2007. p. 133-44.
14. van Niekerk CC, Vooijs GP, Bulten J, van Dijck JA, Verbeek AL. Increased risk of concurrent primary malignancies in patients diagnosed with a primary malignant epithelial ovarian tumor. Mod Pathol 2007;20:384-8.
15. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 1982;50:163-70.
16. Rahaman J, Cohen CJ. Endometrial cancer. In: Kufe DW, Bast RC Jr, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, et al, editors. Cancer medicine. 7th ed. Hamilton (ON): BC Decker; 2006. p. 1522-36.
17. Ramus SJ, Elmasry K, Luo Z, Gammerman A, Lu K, Ayhan A, et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin Cancer Res 2008;14:5840-8.